Antibody engineering describes the production of antibodies using in vitro or in vivo techniques. It allows the design of tailor-made antibodies to fit at best research or therapeutic indications.
Bispecific and trispecific antibodies are essentially antibodies bioengineered to contain two or three distinct antigen-binding domains, which allow these recombinant molecules to bind specifically to more than one target. Harnessing the versatility of multi-specific antibodies, ...Learn More
Spinal cord injuries affect ~17,810 individuals each year in the USA, with no cure yet in sight. Based on the National Spinal Cord Injury Statistical Center, spinal cord injuries often result from vehicular accidents and falls, accounting for 38.6% and 32.2% of injuries since ...Learn More
Organoids, or mini-organs, may be grown from various cell types, including embryonic stem cells, induced pluripotent stem cells, or even adult stem cells. Unlike the classical monolayer cell cultures, organoids are developed to replicate the 3D cellular composition and ...Learn More
Antibody-based therapies are not new, as the use of these molecules to combat human diseases dates back to the 1890s. Antibodies are a key component of the immune system adaptive branch that recognizes a foreign molecule called antigen and mobilize various immune processes to ...Learn More
New evidence COVID-19 antibodies, vaccines less effective against variants. The findings, from laboratory-based experiments and published March 4 in Nature Medicine, suggest that COVID-19 drugs and vaccines developed thus far may become less effective as the new variants become ...Learn More